A case report highlighting drug–drug interactions between 3 life‐saving treatments: Feminizing hormones, antiretrovirals and antituberculosis drugs

Documenti analoghi

• Drug–drug interactions between gender‐affirming hormone therapy and antiretrovirals for treatment/prevention of HIV
  di: Tessa Senneker
  Pubblicazione: (2024)
• Dolutegravir with enteral feeds in intensive care: Case series with therapeutic drug monitoring
  di: Suki Leung, et al.
  Pubblicazione: (2025)
• Clinical characteristics and risk factors for antituberculosis drug‐induced hypersensitivity
  di: Quanxian Liu, et al.
  Pubblicazione: (2024)
• Assessing ChatGPT's capability in understanding and reporting antiretroviral therapy drug–drug interaction effects: Quantitative and qualitative results from the ACCURATE‐DDI study
  di: E. Ready, et al.
  Pubblicazione: (2025)
• The case of dolutegravir plus darunavir antiretroviral regimens: Is it always useful to double the drug doses?
  Pubblicazione: (2024)